Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biochem Pharmacol ; 194: 114818, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34757033

RESUMO

Chronic liver injury promotes the molecular alterations that precede the establishment of cancer. Usually, several decades of chronic insults are needed to develop the most common primary liver tumor known as hepatocellular carcinoma. As other cancer types, liver cancer cells are governed by a common set of rules collectively called the hallmarks of cancer. Although those rules have provided a conceptual framework for understanding the complex pathophysiology of established tumors, therapeutic options are still ineffective in advanced stages. Thus, the molecular alterations that precede the establishment of cancer remain an attractive target for therapeutic interventions. Here, we first summarize the chemopreventive interventions targeting the early liver carcinogenesis stages. After an integrative analysis on the plethora of molecular alterations regulated by anticancer agents, we then underline and discuss that two critical processes namely oxidative stress and genetic alterations, play the role of 'dirty work laborer' in the initial cell damage and drive the transformation of preneoplastic into neoplastic cells, respectively; besides, the activation of cellular senescence works as a key mechanism in attempting to prevent the onset and establishment of liver cancer. Whereas the detrimental effects of the binomial made up of oxidative stress and genetic alterations are either eliminated or reduced, senescence activation is promoted by anticancer agents. We argue that collectively, oxidative stress, genetic alterations, and senescence are key events that influence the fate of initiated cells and the establishment of the hallmarks of cancer.


Assuntos
Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/prevenção & controle , Quimioprevenção/métodos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Alquilantes/administração & dosagem , Animais , Antineoplásicos/administração & dosagem , Antioxidantes/administração & dosagem , Carcinogênese/genética , Carcinogênese/metabolismo , Carcinoma Hepatocelular/genética , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/fisiologia , Quimioprevenção/tendências , Humanos , Neoplasias Hepáticas/genética , Estresse Oxidativo/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA